Wendy L. Dixon, Ph.D.
Board Member
Zevra Therapeutics, Inc. (ZVRA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Wendy L. Dixon, Ph.D.
Wendy L. Dixon, Ph.D. is recorded as Board Member at Zevra Therapeutics, Inc. (ZVRA). Zevra Therapeutics, Inc. reported in an 8-K filed March 30, 2023 that Wendy L. Dixon, Ph.D. was appointed director, effective April 25, 2023.
“On March 27, 2023, the board of directors (the “Board”) of Zevra Therapeutics, Inc. (the “Company”) appointed Wendy L. Dixon, Ph.D. to serve as a director of the Company, effective immediately following the conclusion of the Company’s 2023 Annual Meeting of Stockholders (the "2023 Annual Meeting") to be held on April 25, 2023, to fill the vacancy resulting from Dr. Travis Mickle's resignation from the Board effective as of that day.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-25–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zevra Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christal M.M. Mickle CEO
- Neil F. McFarlane CEO, Board Member
- Richard W. Pascoe CEO
- Matthew R. Plooster Chairman
- Richard Pascoe Chairman
- Tamara A. Favorito Chairman
- Timothy Sangiovanni CFO
- Alicia Secor Board Member
- Alvin Shih, M.D. Board Member
- Christopher A. Posner Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.